BridgeMD
New treatment option for Pediatric Asthma
Official title Towards Digital Management of Paediatric Asthma
ClinicalTrials.gov ID: NCT06902766
What this study is testing
- What it's testing
- This pilot study aims to explore whether a digital approach to managing childhood asthma using connected inhalers and video consultations triggered by alerts from these devices - could work as well as standard in-person care. The connected inhalers track when children use their daily prevention medication and their rescue medication for asthma symptoms.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 4 to 12
You may be able to join if
- Aged 4 to 12, whose asthma has been diagnosed by a physician
- Followed up for their asthma by a pediatrician or pediatric pulmonologist
- With asthma severity corresponding to GINA grades 2, 3 or 4 (Global Asthma Initiative Guidelines)
- Whose controller and reliever treatments are administered using pressurized metered-dose inhalers (p-MDIs)
- With social security
You likely can't join if
- \- Patient who did not use the system within 15 days of the inclusion visit
See the full eligibility criteria
- Aged 4 to 12, whose asthma has been diagnosed by a physician
- Followed up for their asthma by a pediatrician or pediatric pulmonologist
- With asthma severity corresponding to GINA grades 2, 3 or 4 (Global Asthma Initiative Guidelines)
- Whose controller and reliever treatments are administered using pressurized metered-dose inhalers (p-MDIs)
- With social security
- Whose parents or legal guardian(s):
- Have given their written and informed consent for their child's participation and their participation,
- Have a smartphone in the household that can download the application and is compatible with it,
- Are capable, in the opinion of the investigator, of understanding the use of the mobile application and module FRENCH CARE specifically dedicated to the research and the digital inhalers provided. Non-
- Patients with another pathology that could interfere with the evaluation of the endpoints (e.g, bronchopulmonary dysplasia, cystic fibrosis, etc.)
- Patients whose parents or legal representative(s) are, in the opinion of the investigator, unable to understand the purpose of the study and/or express their consent.
- Patients benefiting from State Medical Aid
- \- Patient who did not use the system within 15 days of the inclusion visit
The study team makes the final eligibility decision.
Where it's taking place
- Paris, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 4 years to 12 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.